Close Menu

Keith Robison, lead senior scientist at Infinity Pharmaceuticals and Omics! Omics! blogger, loves citrus. In a recent post, he discusses his anticipation for the completion of the citrus genome project at the Department of Energy’s Joint Genome Institute. “What I’d really like is to have the genetic blueprint for all those wonderful flavors…” Robison writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.